A R T I C L E I N F O
Discovery of divalent metal transporter (DMT1/DCT1/ NRAMP2)
In 1997, one iron transporter was discovered by using different ways. Gunshin et al. used Xenopus laevis oocytes expression system [1] and found divalent cation transporter 1 (DCT1) [2] . DCT1 is a transmembrane glycoprotein and mediates pH-dependent and proton-coupled transport of a broad substrate range of divalent metals, e. Nramp1 (natural resistance-associated macrophage protein 1: solute carrier family 11 member 1, SLC11A1), which regulates host susceptibility to infection with antigenically unrelated intracellular pathogens entrapped in phagosomes, was previously identified in mouse Bcg/Ity/ Lsh locus [3] , and we isolated human NRAMP1 and NRAMP2 as its orthologs [4] [5] [6] . Fleming et al. undertook a positional cloning strategy to identify the causative mutations in the mouse (mk) and the Belgrade rat (b) models, both of which show symptoms of hypochromic microcytic anemia [7] . They demonstrated that the Nramp2 gene is mutated (Gly185Arg) in both animal models of the mk mouse and the b rat [7, 8] .
Later DCT1, encoded by NRAMP2, was renamed as divalent metal transporter 1 (DMT1), and the discovery of this iron transporter DMT1 (SLC11A2) launched the new era of iron metabolism research.
Expression and structure of four DMT1 isoforms

Mechanism of different distribution of four DMT1 isoforms
DMT1 is predicted to have 12 transmembrane domains, and both its N-and C-terminal regions are present in the cell cytoplasm ( Fig. 1 ) [2, 3, 9] . Expression of DMT1 is elaborately regulated in a tissue-and cell-type specific and iron-dependent manner. Gunshin et al. reported that DMT1 mRNA levels are increased in the duodenum of iron-deficient animals [2] . This regulation has been observed for DMT1 mRNA harboring an iron-responsive element (IRE) in the 3′-untranslated region [2, 10, 11] which can bind to iron regulatory proteins (IRPs) under iron deficiency [12] , leading to stabilization of transcripts and subsequent increased synthesis of DMT1 polypeptide. It should also be noted that DMT1 mRNA includes additional non-IRE-containing isoform, which is generated by alternative splicing and unresponsive to iron concentration [13] [14] [15] . They code different amino acid sequences in their C-terminal regions and generates two different DMT1 isoforms (I and II). DMT1 isoform II (DMT1-II) mRNA, not harboring IRE, encodes a protein that has a different C-terminal 25 amino acid segment instead of the 18 amino acid segment encoded by another isoform mRNA (DMT1-I), harboring IRE [14, 15] . Moreover, alternative use of DMT1 gene promoters generates two variant DMT1 transcripts that differ in nucleotide sequences encoding the 5′-untranslated region and their subsequent N-terminal amino acids [16] . A polypeptide transcribed from the 5′-upstream promoter and exon 1A is indicated as DMT1A, and a polypeptide transcribed from another promoter and exon 1B is indicated as DMT1B. DMT1A contains extra 29 amino acids on the upstream of DMT1B. Together, DMT1 has four different isoforms, A-I, A-II, B-I and B-II [16, 17] .
All four of the DMT1 isoforms contain two asparagine residues, Nlinked glycosylation sites, in their predicted extracellular loop between 7th and 8th transmembrane domains [14, 18] . N-linked glycosylation is widely observed to be crucial for proper folding of protein and occurs in the endoplasmic reticulum (ER) and Golgi apparatus. DMT1 appears on the western blot as the 90-116 kDa smear or ladder-like bands, and peptide N-glycosidase F treatment results in a shift of the apparent molecular mass from 90-116 to 50 kDa [14] . They are heavily glycosylated in the Golgi, folded properly and transferred to plasma membrane ( Fig. 1) [15] .
At the plasma membrane, each DMT1 isoform follows the different pathway and shows different destination. Namely, DMT1A-I is mainly localized at plasma membrane, DMT1A-II and DMT1B-II are at recycling endosome and DMT1B-I is at late endosome/lysosome [15, 17] . Using a technique of mutagenesis, we have revealed the mechanism how each DMT1 isoform follows the different pathway. Alternation of one leucine 16 residue (Leu16) on extra 29 amino acid sequence in Nterminal cytoplasmic region of DMT1A-I isoform caused its mislocalization, and it indicated that Leu16 had a role as a retention signal for plasma membrane [17] . DMT1A-I harboring the mutated nonfunctional retention signal is mislocalized to late endosome/lysosome as observed in the case of a proper DMT1B-I localization (Fig. 1) . DMT1A-I is expressed on apical membrane of polarized absorptive cells, and Nglycosylation mutants of DMT1A-I are no longer detected apically restricted, but are found on both the apical and basolateral membranes at equivalent levels [15, 17] . Thus, the N-glycan of the DMT1 isoform plays a critical role in the polarized sorting of the molecule to the apical membrane. Other three DMT1 isoforms are principally endocytosed by clathrin-dependent manner [18] . On the C-terminal cytoplasmic region of DMT1A/B-II isoforms, there is a sequence Øx(Leu/Met)x (where Ø can be any hydrophobic amino acid and x can be any amino acid), which is required for the binding of DMT1A/B-II to the retromer cargorecognition complex and represents a novel retromer-binding motif ( Fig. 1) [15, 19] . It has been well known that retromer is a complex of proteins that has been shown to be important in recycling transmembrane receptors from endosomes to the trans-Golgi network (TGN). Retromer is composed of a vacuolar protein sorting (Vps) trimer containing Vps26, Vps29 and Vps35 [20] and some membrane-associated sorting nexin dimer (SNX1, SNX2, SNX5 and SNX6) [21] . A complex of Vps26, Vps29 and Vps35 can directly bind to DMT1A/B-II isoforms, not DMT1A/B-I, and distributes DMT1A/B-II isoforms to recycling endosome, in which transferrin receptor 1 (TfR1) was colocalized. TfR1 is transported to the recycling endosome by a retromer-independent manner, whereas DMT1A/B-II is directly recognized by the retromer complex and transported to the TGN before endosomes are completely matured. At the TGN, DMT1A/B-II is then transported to the recycling endosome. Thus, the Øx(Leu/Met)x motif is the recycling signal responsible for proper endosomal recycling of DMT1A/B-II. TfR1 and DMT1A/B-II are functionally coupled to incorporate Tf-bound iron (TBI) in the Tf-TfR1 cycle [22] . Subsequently both TfR1 and DMT1A/B-II are recycled back to the plasma membrane. DMT1B-I has neither a plasma membrane retention signal in its N-terminus nor a retromer binding site in its C-terminus. Therefore, this molecule is not capable to [14] . N-terminus in longer form of DMT1A contains a plasma membrane anchoring signal and C-terminus in DMT1A-II and DMT1B-II contains a retromer binding site, which works as a recycling endosome distribution signal.
be recognized by the retromer complex and cannot escape from maturing endosomes. It is consequently transported to late endosome/lysosome [19] .
Different expression level of DMT1 isoforms
The protein expression levels of these four DMT1 isoforms differ among tissue types: DMT1A-I is highly expressed in duodenum and kidney and the absorptive cells can incorporate non-Tf-bound iron (NTBI) into cytosol from food or urine, whereas DMT1B-I is expressed in the reticuloendothelial system and uptakes iron from late endosome/ lysosome into cytosol. DMT1A-II is expressed in the duodenum; its expression level is quite low compared with other isoforms. DMT1B-II is expressed in peripheral tissues and incorporates iron released from transferrin in the recycling endosome [15, 16] . DMT1 expression pattern is nicely regulated depends on the types of cells or tissues. It is still unclear the details of transcriptional and translational processes how cells can change the different promoters or what is a trigger to cause alternative splicing to generate a specific DMT1 mRNA for the most efficient iron uptake.
Structure of DMT1
Human DMT1 and its homolog protein NRAMP1 are highly conserved across all kingdoms of life and thus likely share a common transport mechanism. Highly homologous prokaryotic NRAMP family members, Staphylococcus capitis DMT (ScoDMT) [23] and Eremococcus coleocola DMT (EcoDMT) [24] , show sequence identity of 30% with human DMT1 and underlines the strong degree of conservation in NRAMP family [24] . DMT1 functions as secondary active transporter that couples the transport of ferrous iron to the transport of proton in the same direction, with a K M in the low μM range.
Recently, the structural analysis has gradually revealed how DMT1 organizes its conformation changes to pass both iron and proton through inside the transporter [2, 24] . It is suggested that DMT1 displays a pseudo-symmetric relationship between two structurally analogous domains consisting of 1-5 transmembrane domains and 6-10 ones. Both domains are intertwined and aligned in opposite orientation within the membrane. It is speculated that metal binds to conserved metal binding residues in transmembrane domains 1 and 6, followed by their conformation changes to transport protons effectively. By mutation analysis, it is suggested that a conserved histidine on transmembrane domain 6 likely plays a central role in proton transport [24] . To clarify whole mechanism from the binding of ferrous iron to DMT1 to the transferring into cytosolic iron chaperone, the further analysis is still needed.
Cell-type specific iron uptake
Iron uptake in intestine
In mammals, dietary iron occurs in two major forms, heme and nonheme. Both forms of iron are taken up by the proximal small intestinal epithelium, primarily the duodenum. In the form of non-heme iron, it is known that ferrous iron is more efficiently absorbed than ferric iron [25] . However, because most dietary non-heme iron is in form of ferric iron complexes, these must be reduced to yield ferrous form before iron can be successfully transported by DMT1 expressed on the apical membrane of enterocyte. Mackie et al. identified duodenal cytochrome b (DcytB) which is expressed at a brush-border surface and has ferric reductase activity [26] . Collaborating with DcytB, DMT1A-I can uptake ferrous iron derived from food into cytosol (Fig. 2 left) . Heme iron constitutes only a small fraction of the available dietary iron, but is believed to be more readily absorbed than non-heme iron. Dietary heme can be transported across the apical membrane and be subsequently catabolized by heme oxygenase 1 (HO1) [27] . This process produces ferrous iron in the cytosol of absorptive epithelium. Ferrous iron derived from both heme and non-heme irons can be immediately caught by iron chaperone. And then iron chaperone may transfer ferrous iron from apical side to basolateral side (see the detailed mechanism of iron chaperone in the Sections 5 and 6).
As iron in cytosol reaches to basolateral membrane, ferroportin 1 (FPN1, SLC40A1), which is the sole cellular efflux channel for iron, is localized at this side of plasma membrane [28] [29] [30] . Based on the recent structural study, FPN1 has 12 transmembrane domains and can transport only ferrous iron [31] . Hephaestin (HEPH) is a multicopper ferroxidase required for basolateral export of iron from duodenal enterocytes [32] . In HEPH mutant mice, FPN1 is still localized at basolateral membrane but HEPH is present only in the supranuclear compartment, which diminishes iron exit from the enterocytes into the circulation [32] . After FPN1 exports iron from the enterocytes, HEPH immediately oxidizes ferrous iron to ferric iron, which is subsequently trapped by Tf in the body fluid. Through these multiple steps, iron can be incorporated into a body (Fig. 2 left) .
Iron uptake in erythrocyte through Tf-TfR1 pathway
Most types of cell including erythrocyte use the Tf-TfR1 mediated pathway to uptake iron into cytosol ( Fig. 2 middle) [33] . Tf is a glycoprotein that exists in the circulation and binds two ferric iron tightly. Once two holo-Tf bind to TfR1 on the plasma membrane, Tf-TfR1 complex is endocytosed and delivered to endosomes, which are acidified to pH 5.5-6.0 through the action of an ATP-dependent proton pump [34] . Endosomal acidification weakens binding of ferric iron to Tf and the iron is released from Tf. On the endosomal membrane, there is another enzyme possessing the ferric reductase activity, six-transmembrane epithelial antigen of the prostate 3 (Steap3), which is required for changing ferric iron to ferrous iron to let iron pass through DMT1A/B-II [35] . The apo-Tf-TfR1 complex is recycled back to the plasma membrane for another round of the Tf-TfR1 cycle (Fig. 2  middle) .
Iron recycling in phagocyte
Adult humans have about 25 trillion RBCs and each second we recycle about 2.5 million RBCs by erythrophagocytosis in macrophages of the reticuloendothelial system [36] . The recycled iron from RBCs degradation by reticuloendothelial system covers more than 90% of iron which is necessary for daily requisition. Damaged or senescent RBC engulfed in macrophage is proceeded through several steps (Fig. 2  right) : heme is released from the degradation products of hemoglobin that is a major component of RBC, and is translocated into cytosol via HRG-1, which is a transmembrane heme permease expressed in macrophage and localized at lysosomal membrane [17, 37, 38] . In cytoplasm, HO1, located on the cytosolic face of smooth ER, catabolizes heme by receiving electrons from NADPH-cytochrome P450 reductase (CPR) and then ferrous iron is released [17, 39] . FPN1 is highly expressed in macrophage and it pumps out ferrous iron into circulation for recycling. Ceruloplasmin (CP) works as another multicopper ferroxidase required for catalyzing iron oxidation from ferrous to ferric form, and it is necessary for efficient iron loading into apo-Tf [40] . Excess intracellular heme may result in oxidative stress and membrane injury, and Feline leukemia virus subgroup C receptor-related protein 1 (FLVCR1, SLC49A1) mediates heme export [41] . FLVCR1 has 12 transmembrane domains and is located in plasma membrane. It is known that FLVCR1 is important for heme pool regulation in cytosol, and essential in erythropoiesis [41, 42] .
Some proteins containing iron, such as ferritin, are degraded in lysosome and iron is released in the lumen of lysosome. This iron is supposed to be transported through DMT1B-I or its homolog NRAMP1, both of which are localized at lysosomal membrane. Therefore, each DMT1 isoform is expressed at the appropriate membrane and then cells can uptake and use iron efficiently.
Degradation of DMT1
There are two major mechanisms which regulate DMT1 expression: one is mRNA stabilization through IRE-IRP mechanism [43] and the other is protein degradation through ubiquitin-proteasome system [44] . DMT1A/B-I harbors IRE sequence in the 3′-untranslated region. DMT1A-I can function at the apical membrane of absorptive enterocyte and DMT1B-I resides in late endosome/lysosome to retrieve iron from the lumen. Both isoforms could be controlled by the IRE-IRP regulatory system [43] . DMT1A/B-II, residing in recycling endosome, is functionally coupled to Tf-TfR1 cycle for the uptake of TBI. Most of dailyingested and recycled iron is used in erythroid cells to produce heme proteins and Tf-TfR1 cycle coupled to DMT1A/B-II is a major iron uptake pathway in these cells. DMT1A/B-II does not harbor IRE sequence in their mRNAs [43, 45] and IRE-IRP regulatory system could not be a major regulator of iron acquisition in erythroid cells. Thus, it is supposed that the main regulatory mechanism dictating DMT1 protein expression in these cells might be a transcriptional control and/or a protein degradation control.
Protein modification by ubiquitination plays an essential role in diverse cellular processes. Degradation of a protein via the ubiquitin proteasome pathway involves two discrete and successive steps: tagging of the substrate protein by the covalent attachment of multiple ubiquitin molecules; and the subsequent degradation of the tagged protein by the 26S proteasome, composed of the catalytic 20S core and the 19S regulator. Ubiquitin becomes covalently linked to itself and/or other proteins either as a single molecule or as poly-ubiquitin chains. The attachment of ubiquitin to the ε-amine of lysine residues of target proteins requires a series of ATP-dependent enzymatic steps by E1 (ubiquitin activating), E2 (ubiquitin conjugating) and E3 (ubiquitin ligating) enzymes. E3 binds to substrate proteins and also to an E2 to form an E2-E3-substrate complex. It is the recognition and formation of the complex that has the highest level of substrate specificity for the conjugation cascade. It has been known that E3 ubiquitin ligases are characterized by the conserved structural domains and the mechanism by which ubiquitin is transferred from the E2 to the substrate. They fall into three different families, really interesting new gene (RING), homologous to E6AP C-terminus (HECT) and RING-between-RING (RBR) ligases [46] .
One of the E3 ligases, the Nedd4 family of WW-HECT-type E3s, is known to regulate a number of ion channels and receptor via ubiquitination and endocytosis [47] . Nedd4 is a highly conserved gene in eukaryotes, and is the founding member of the Nedd4 family of E3 HECT ubiquitin ligases, consisting of nine members in humans (e.g. Nedd4-2, ITCH, and etc). The Nedd4 ligases commonly bind their cognate substrates directly via their WW domains, which in most cases interact with the proline-rich PPxY (PY) motifs in the target proteins [48] . Two such proteins, Nedd4 family-interacting protein 1 (NDFIP1) and NDFIP2, were initially identified as Nedd4 WW domain-binding proteins [49, 50] . Both NDFIP1 and NDFIP2 are ubiquitously expressed at the Golgi and contain two PPxY motifs [50] . They function as adaptor proteins and interact with Nedd4 family ligases via WW-PPxY interaction and then mediate the ubiquitination and subsequent degradation of DMT1 by recruiting E3 ligases to DMT1 (Fig. 3) . The interaction between NDFIP and DMT1 is elevated by iron exposure [51] , which suggests that this ubiquitin-mediated DMT1 degradation system is important for iron homeostasis [52] . This system is conserved in Saccharomyces cerevisiae and the NDFIP-like protein Bsd2p negatively regulates Smf1p, a metal ion transporter similar to DMT1. Bsd2p recruits Rsp5, the Nedd4 homolog in S cerevisiae, to promote Smf1p ubiquitination and trafficking to the vacuole for degradation [53] . DMT1 expression is strictly regulated by both generating and degrading pathways. Fig. 2 . Cell-type specific iron uptake mechanism. In absorptive cells DMT1A-I localized at apical membrane is involved in non-Tf-bound, ferrous iron uptake with the help of Dcytb ferric reductase activity. In most type of cells including erythrocytes, Tf-bound iron is uptake through Tf-TfR1 pathway. In endosome, low pH condition, ferric iron is released from Tf, reduced to ferrous iron by Steap3 and then DMT1A/B-II localized at endosomal membrane imports it into cytosol. In phagocytes, cells phagocyte damaged or senescent RBC. Heme produced by RBC degradation is transported into cytosol by HRG-1 localized at lysosomal membrane. Heme is catalyzed into ferrous iron by HO-CPR complex localized at cytoplasmic face of ER. Ferrous iron is exported through FPN1 into body fluid. The released iron is important supply for new RBC generation. Heme can be exported by FLVCR1.
Iron chaperone, PCBP2, collaborates with iron transporters for direct iron transporting
Poly r(C) binding proteins (i.e. PCBP1-4) were first reported as RNA-binding molecules [54] . Each four PCBP isoform contains three Khomology (KH) domains [55] which bind single-stranded RNA and DNA [56] . The two consecutive domains at the N-terminus (KH1 and KH2) are followed by a long spacer and a third KH domain at the Cterminus (KH3). KH domain of PCBPs is categorized as a classical type-1 KH and has a conserved GXXG loop, which interacts with the RNA backbone [57] . Many reports indicate that PCBPs play important roles in posttranscriptional and translational regulation by interacting with single-stranded poly r(C) motifs in target mRNAs [58, 59] . PCBP2 mRNA is thought to be retrotransposed to generate PCBP1, an intronless gene [60] . PCBP2 and PCBP1 have paralogous genes (PCBP3 and PCBP4) which are thought to have arisen as a result of duplication events of entire genes. PCBP1 exhibits the greatest sequence similarity (81%) to PCBP2 [61] . Of the PCBPs, only PCBP1 and PCBP2 are ubiquitously expressed at high levels in mammalian cells. It was previously reported that the authentic protein concentration of PCBP2 in cells was 100 nM [62] . In fact, PCBPs are abundantly expressed and estimated to occupy ∼ 0.5% of total proteins [63] . PCBP3 and PCBP4 are expressed at low levels in some tissues and at some phases of development.
Recently, it has been cleared that there are different notable PCBPs functions, namely, iron binding activity and transferring iron to other molecules [64] . Interestingly, studies by both our in vitro experiments [9, 65, 66] and others in vivo experiments using Pcbp2 −/− mice [67] have demonstrated that PCBP2 possesses a non-redundant role though PCBP2 highly shares amino acid sequence with other members of PCBP group. The PCBPs have no transmembrane domains and are known as soluble proteins, mainly residing in the cytosol. However, fractionation experiments showed that considerable amount of PCBP2 was detected in the microsomal fraction [66] . This observation suggested that PCBP2 may interact with membrane-associated protein. Of interest, the amount of PCBP1 in the microsomal fraction was less compared with PCBP2. Hence, the membrane-association properties must be somewhat different between PCBP1 and PCBP2. In the following sections, we focus on PCBP2 and describe its detailed function as an iron chaperone. It has been reported in many articles that hydroxyl radical formation is catalyzed by ferrous iron in the Fenton reaction, and this radical causes cell damage and organ dysfunction [68] . The major iron transporters, DMT1 and FPN1, can only transfer ferrous not ferric iron. In circulating plasma, ferrous iron exported through FPN1 is immediately oxidized to ferric iron by CP or HEPH, and then bound to Tf [69] .
Making an iron complex with proteins is greatly conductive to reducing the production of hydroxyl radical in cytosol and body fluid. Though the Fenton reaction is widely known to be harmful, it has been generally described that ferrous iron, incorporated by DMT1 or generated by the degradation of iron-containing proteins in cytosol, is afloat as a labile iron pool in cytosol. We thus hypothesized that some proteins, such as Tf in extracellular fluid, should ubiquitously reside in cytosol and bind ferrous iron to keep it not only at unhazardous state but also in bioavailable form, because ferritin in cytosol is an iron-storage molecule and is not readily available for various metabolic pathways. It was revealed that the C-terminal cytoplasmic region of DMT1 includes a structural requirement for a novel endocytic recycling signal [14, 18] , whereas the function of the N-terminal cytoplasmic regions, consisting 99 and 70 amino acids in DMT1A and DMT1B, respectively, was not clarified. We have identified a novel function in the N-terminal region of DMT1 by which DMT1 can bind to PCBP2 [9] . Iron-depleted PCBP2, not iron-loaded one, is remarkably capable of binding to DMT1. On the other hand, iron-loaded DMT1 can interact with PCBP2, and iron-depleted DMT1 cannot (Fig. 4 left) . Once PCBP2 expression is diminished, iron uptake via DMT1 is significantly attenuated. PCBP2 can bind ferrous iron in vitro in a 3 Fe:1 PCBP2 stoichiometric ratio with low micromolar affinity [64] . The transfer of ferrous iron from DMT1 to PCBP2 occurs via direct binding of these two molecules. The critical role of the KH2 domain of PCBP2 in its interaction with DMT1 is demonstrated by the in vitro and in vivo experiments [9, 65] . It is speculated that the iron bound to the iron-binding sites in DMT1 causes a conformation change in the iron-depleted PCBP2-DMT1 complex, followed by direct transferring ferrous iron from DMT1 to PCBP2 and turning back to the original DMT1 conformation state to pass through another iron.
Structural analysis demonstrates that both N-and C-terminal regions of FPN1 are in the cell cytoplasm [31] . PCBP2, not the other PCBP members, can bind to C-terminal cytoplasmic region of FPN1, and the KH2 domain is a crucial region for the interaction [65] . Iron-loaded PCBP2 can interact with iron-depleted FPN1. Iron-depleted PCBP2 can neither bind to iron-depleted FPN1 nor iron-loaded FPN1. Moreover, silencing of PCBP2 attenuated iron export through FPN1. Namely, ironloaded PCBP2, interacting solely with iron-depleted FPN1, directly 4 . Safe and free-iron transport mechanism through iron chaperone PCBP2, PCBP2 contains three KH domains and the KH2 domain is important for binding to both DMT1 and FPN1. The KH3 domain is important for the HO1-PCBP2 interaction. Iron-depleted PCBP2 (apo-form) can bind to N-terminal cytoplasmic region of DMT1 and directly receive iron. Once PCBP2 is filled with iron, iron-loaded PCBP2 (holo form) is released from DMT1. In the case of FPN1, iron-loaded PCBP2 (holo form) can bind to C-terminal cytoplasmic region of FPN1 and directly donate iron to FPN1. Once PCBP2 loses iron, irondepleted PCBP2 (apo-form) is released from FPN1.
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Free Radical Biology and Medicine 133 (2019) [55] [56] [57] [58] [59] [60] [61] [62] [63] donates iron to FPN1 (Fig. 4 right) . Once PCBP2 has lost iron, it is released from FPN1 and binds newly incorporated iron. It is hard to find any similarity in their sequences between N-terminal cytoplasmic region of DMT1 and C-terminal cytoplasmic region of FPN1, which interact specifically with iron-depleted and iron-loaded PCBP2, respectively. It suggests that some conformational alternations in PCBP2, mediated by the iron binding, may be necessary for the binding to two different cytoplasmic regions. It is also needed to take into account a conformational alteration in each cytoplasmic region of the transporters, induced by the iron passing through the molecules. Considering the roles of PCBP2 in iron uptake and release, it can be speculated that it might play a key function as a "gateway keeper" to distribute iron safely between the iron importer/exporter and the cytosol.
Heme degradation mechanism by HO1-CPR-PCBP2 metabolon
Heme degradation and iron-recycling pathway are working mainly in macrophage. As damaged or senescent RBC is engulfed by macrophage, the hemoglobin-binding haptoglobin and the heme-binding hemopexin bind to the macrophage scavenger receptor CD163 [70] and the low density lipoprotein receptor-related protein LRP/CD91 [71] , respectively, and these receptor-ligand complexes are endocytosed by macrophage. Then RBC, the hemoglobin-binding haptoglobin and the heme-binding hemopexin are degraded in lysosome. HRG-1, strongly expressed in macrophage and specifically localized to the phagolysosomal membrane, is essential for macrophage iron homeostasis and transports heme from the lysosome to the cytosol during erythrophagocytosis [38] . The mammalian HO enzymes catabolize intracellular heme to biliverdin, carbon monoxide, and ferrous iron at the expense of molecular oxygen using electrons donated by CPR [39] . HO is anchored to smooth ER by its C-terminal transmembrane region, whereas the N-terminal cytoplasmic region plays a key role in its catalytic activity for heme catabolism [17, 72] . Ferrous iron generated by heme degradation is one of the biggest iron sources especially in phagocytes or absorptive enterocytes. Thus, we hypothesized that iron chaperone(s) should be necessary for the safe intracellular iron delivery and modulate ferrous iron produced through this metabolic pathway. We have demonstrated that HO family members, HO1 and HO2, specifically interact with PCBP2 but not PCBP1, PCBP3, or PCBP4, and PCBP2 competes with CPR for HO1 binding [66] . In heme-loaded cells, heme prompted HO1-CPR complex formation and decreased the HO1-PCBP2 interaction. In vitro experiments with purified proteins indicated that HO1 can bind to PCBP2 in the presence of heme, whereas ironloaded PCBP2 demonstrates markedly lower affinity for HO1 than irondepleted PCBP2. Iron evoked PCBP2 dissociation from HO1. The KH3 domain of PCBP2 is important for the HO1-PCBP2 interaction. HO1 and PCBP2 form a complex in a 4:1 M ratio, and PCBP2 may receive multiple ferrous iron atoms from HO1 oligomer. Collectively, our previous study proposed an integrated model of the putative function of PCBP2 in heme catabolism via HO1 and the iron transport metabolon (Fig. 5) . We have thus elucidated the relationship between the iron-related molecules (importer DMT1, exporter FPN1 and HO1-CPR complex) and PCBP2, and henceforth address iron-depleted PCBP2 as apo-PCBP2 and iron-loaded PCBP2 as holo-PCBP2. Both HO1 and CPR are localized at the ER membrane, and apo-PCBP2 binds to HO1 under steady-state condition (Fig. 5) . Once heme is transported through the cell, it can bind to its binding site on HO1. This is the first "trigger" to commence the heme degradation process. Heme fills the heme-binding site on HO1, which then evokes an alteration in the conformation of the enzyme. HO1 and CPR can form a complex via their cytoplasmic regions and this alteration induces CPR to become tightly bound to HO1 to transfer electrons to degrade heme and enables the dissociation of apo-PCBP2. After heme degradation, CPR dissociates from HO1 and apo-PCBP2 binds to HO1 to accept the released ferrous iron. At the final step of the heme degradation process, holo-PCBP2 then dissociates from HO1 to transfer its metal to other protein acceptors. After dissociation of holo-PCBP2, another apo-PCBP2 molecule then binds to HO1. PCBP2 resides mainly in cytosol and can function to retrieve ferrous iron from the heme degradation, which is held on the cytosolic face of ER. PCBP2 changes its subcellular distribution after incubation of cells with heme, leading to a decrease in its levels in the microsomal fraction and an increase in the cytosol. The interaction between apo-or holo-PCBP2 and HO1 is hypothesized to ensure that PCBP2 remains in the microenvironment of HO1 and CPR. Though PCBP2 is not necessary for heme degradation activity of HO1, it plays a role as a part of an integrated complex of proteins to form a functional metabolon (HO1-CPR-PCBP2) to prevent the generation of free/labile iron in cytosol (Fig. 5) [66] . The precise molecular processes involved remain to be investigated in future studies.
Other iron transporters
It has been well known that DMT1 is the most prominent iron transporter in cells. Recently, it is becoming clear that other metal transporters play some roles in iron transport.
NRAMP1 (SLC11A1) is a paralog protein of DMT1, shares 65% amino acid sequence identity, and is mainly expressed in macrophage [6, 73, 74] . It is observed in the membrane of lysosome and the pathogen-containing phagosome and involved in pro-inflammatory responses against Salmonella, Leishmania, and Mycobacteria [75, 76] . NRAMP1 as well as DMT1 has 12 transmembrane domains and exhibits iron transport activity. It pumps out iron from phagosome to cytosol and may help to inhibit intracellular bacterial growth for reducing iron which is needed for the bacteria. It has been still unclear which protein can bind to NRAMP1 and work as iron receiver. Future work about NRAMP1 iron transport activity is necessary to clarify the pro-inflammatory response mechanism controlling the innate immunity or susceptibility to infection with intracellular pathogens in phagocytes.
SLC39A proteins are members of the broader ZRT-, IRT-like protein (ZIP) family of metal ion transporters found in organisms at all phylogenetic levels [77] . There are 14 SLC39A-related proteins encoded by the human genome and most ZIP transporters have eight predicted transmembrane domains and a similar predicted topology in which the N-and C-terminal ends of the protein are located on the outside surface of the plasma membrane. ZIP proteins have been found to transport metal ions from the cell exterior or lumen of intracellular organelles into cytosol. It has been reported that some ZIP proteins, especially ZIP8 [78] , ZIP13 [79] and ZIP14 [80] have an important role as an iron transporter. ZIP8 and ZIP14 shares more than 50% of amino acid sequence and are mainly located in plasma membrane to facilitate to transport NTBI. DMT1 exhibits maximal iron transport activity at pH 5-6, however, ZIP14 does at pH 7.5, making it well suited for iron uptake from the plasma, such as NTBI in circulation [81] . Some studies using mice have shown that plasma NTBI is rapidly cleared by liver and pancreas. Expression level of DMT1A-I, localized at plasma membrane, is very low in both liver and pancreas, whereas ZIP14 is abundant in these tissues. These studies demonstrate that in liver and pancreas, NTBI is taken up mainly by hepatocytes and acinar cells via ZIP14 but not DMT1 [80, 81] . It has been reported that ZIP13 is localized at ER/ Golgi with both its N-and C-termini in the lumen side and is responsible for zinc importing from ER/Golgi to cytosol in mouse cell [82] . ZIP13 is also involved in moving iron from cytosol into the secretory compartments in fly and its mutants in human can cause abnormality of collagen synthesis because of iron deficiency in ER [79] . During collagen synthesis, ER is the place where it is modified. Hydroxylation of lysyl and prolyl residues in collagens are catalyzed by lysyl hydroxylase and prolyl 4-hydroxylase, respectively. Both enzymes, requiring ferrous iron as a cofactor, reside in the lumen of ER, the secretory compartment for collagen synthesis [79] . ZIP13 additionally possesses some domains that are not found in other ZIP family members [82] . The importance of iron transport between ER and cytosol has just reported and it is becoming clear that ZIP proteins make a big contribution to iron Heme degradation mechanism by HO-CPR-PCBP2 metabolon, Once heme is transported through the cell, it can bind to its binding site on HO1. Heme binding to HO1 alters HO1 structure, which then enables CPR to become tightly bound to HO1 and transfer electrons to commence heme degradation. This conformational change of HO1 is suggested to cause HO1-PCBP2 dissociation. Then rapidly, CPR dissociates from HO1 and iron-depleted PCBP2 (apo-PCBP2) then binds to HO1 to accept the released ferrous iron. At the final step, iron-loaded PCBP2 (holo-PCBP2) dissociates from HO1 to transfer its metal to other protein acceptors. After dissociation of holo-PCBP2, another apo-PCBP2 molecule then binds to HO1. This schema is cited from reference [58] and modified in this review. Fig. 6 . Ingenious mechanism of iron transport, In summary, PCBP2 is involved in all three kinds of iron uptake pathways; NTBI uptake through DMT1A-I, TBI uptake through DMT1A/B-II and iron released from heme degradation by HO. Moreover, PCBP2 can transfer iron to iron exporter, FPN1. PCBP2 plays an important role as an iron "gateway keeper". This schema is cited from Ref. [8] and modified in this review. transport. Our recent findings indicate PCBP2 functions as a gateway keeper which binds to the transporters of DMT1 or FPN1 [9, 65] , but the interaction among metal ion transporters of ZIPs and chaperone proteins still remains unknown. Future work is needed how ZIP proteins receive cytosolic iron or how they release iron to cytosol.
Conclusions
This review summarizes DMT1 and a recently discovered iron chaperone molecule, PCBP2 (Fig. 6) . Iron homeostasis is regulated very strictly and the major iron importer, DMT1, is regulated by three kinds of ways: 1) translational regulation through IRE-IRP binding, 2) degradation by ubiquitination with depending on iron level, and 3) interaction of PCBP2 as a gateway keeper. Human has splendid multiple regulatory systems to maintain iron level in a narrow range.
The mechanism how to transfer ferrous iron safely has puzzled scientists for many years. In the case of copper, multiple chaperone proteins are involved in copper transport and each chaperone has specific binding partner. PCBPs are only known iron chaperone molecules so far and there is a possibility that some different proteins work as an iron chaperone. Mitochondrion is a major iron consumer in cell but it has not been disclosed how iron can reach to mitochondria. Some reports suggest that a direct transfer of iron from Tf-containing endosome to the mitochondrion occurs, and a by-passing the cytosol by a possible direct contact between the endosome and mitochondrion could be an iron transporting pathway to mitochondria in erythroid cells [83] . However, it is not well-defined how much this mechanism contributes to the iron flux into mitochondria and whether it also functions in nonerythroid cells. When cells are loaded with heme, the levels of both cytosolic and mitochondrial iron pools increase [84] . It indicates ferrous iron generated by heme degradation is initially released into cytosol and then transferred to mitochondria. There should be a particular pathway working for transporting cytosolic iron, especially produced by heme degradation in cytosol, to mitochondria or FPN1. Iron is needed not only for heme and iron sulfur cluster generated in mitochondrion, but also for a variety of cytoplasmic and nuclear functions. To make clear about iron homeostasis mechanism in whole types of cells, it is necessary to reveal the regulation of iron transporters and iron chaperones.
